VALSARTAN-HYDROCHLOROTHIAZIDE 160-12.5 MG TAB
For 30 tablets
Pharmacies pay
$3.04 filed
30 × $0.10137 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$12.42 filed
30 × $0.41408 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
4.1× estimated
Medicare paid 4.1× what pharmacies pay.
Part D averages every strength and form sold under “Valsartan-Hydrochlorothiazide” / “Valsartan/Hydrochlorothiazide” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$8.50 estimated
$3.04 + $0.46 (15%) + $5.00 fee per fill = $8.50
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
VALSARTAN-HYDROCHLOROTHIAZIDE 160-12.5 MG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as valsartan and hydrochlorothiazide.
FDA gives its dosage form as tablet, film coated and its route as oral.
FDA lists 5 labelers (the companies named on the label) for its NDCs, among them Mylan Pharmaceuticals Inc., Macleods Pharmaceuticals Limited and Solco Healthcare US, LLC.
FDA lists it under 2 Established Pharmacologic Classes: Angiotensin 2 Receptor Blocker and Thiazide Diuretic.
The NADAC file of 2026-10-14 prices it under 8 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $3.04 for 30 tablets (30 × $0.10137 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 5 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Alembic Pharmaceuticals Inc. | 2 | $0.10137 per EA filed |
| Aurobindo Pharma Limited | 2 | $0.10137 per EA filed |
| Macleods Pharmaceuticals Limited | 2 | $0.10137 per EA filed |
| Mylan Pharmaceuticals Inc. | 1 | $0.10137 per EA filed |
| Solco Healthcare US, LLC | 1 | $0.10137 per EA filed |
All 8 NDCs, with labeler and price
- 00378-6322-77 · Mylan Pharmaceuticals Inc. · $0.10137 per EA · eff. 2026-09-23 filed
- 33342-0075-10 · Macleods Pharmaceuticals Limited · $0.10137 per EA · eff. 2026-09-23 filed
- 33342-0075-15 · Macleods Pharmaceuticals Limited · $0.10137 per EA · eff. 2026-09-23 filed
- 43547-0312-09 · Solco Healthcare US, LLC · $0.10137 per EA · eff. 2026-09-23 filed
- 62332-0080-71 · Alembic Pharmaceuticals Inc. · $0.10137 per EA · eff. 2026-09-23 filed
- 62332-0080-90 · Alembic Pharmaceuticals Inc. · $0.10137 per EA · eff. 2026-09-23 filed
- 65862-0548-90 · Aurobindo Pharma Limited · $0.10137 per EA · eff. 2026-09-23 filed
- 65862-0548-99 · Aurobindo Pharma Limited · $0.10137 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
7 other products in the NADAC file share the FDA nonproprietary name valsartan and hydrochlorothiazide with VALSARTAN-HYDROCHLOROTHIAZIDE 160-12.5 MG TAB.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| DIOVAN HCT 80-12.5 MG TABLET | $10.5648 per EA filed | $11.925 per EA filed |
| DIOVAN HCT 160-12.5 MG TAB | $11.47643 per EA filed | $11.925 per EA filed |
| DIOVAN HCT 320-25 MG TABLET | $16.37958 per EA filed | $11.925 per EA filed |
| VALSARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TAB | $0.09732 per EA filed | $0.41408 per EA filed |
| VALSARTAN-HYDROCHLOROTHIAZIDE 160-12.5 MG TAB this page | $0.10137 per EA filed | $0.41408 per EA filed |
| VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB | $0.12141 per EA filed | $0.41408 per EA filed |
| VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB | $0.18604 per EA filed | $0.41408 per EA filed |
| VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB | $0.1916 per EA filed | $0.41408 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-07, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 8 NDCs’ NADAC prices is $0.10137 per EA filed.
Of the 107 other products in FDA’s Angiotensin 2 Receptor Blocker class priced per EA, 95 have a higher middle NADAC price and 12 a lower one. The one in the middle is OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5, at $1.15137 per EA filed (eff. 2026-09-23).
Of the 68 other products in FDA’s Thiazide Diuretic class priced per EA, 56 have a higher middle NADAC price and 12 a lower one. The one in the middle is AMILORIDE HCL-HYDROCHLOROTHIAZIDE 5-50 MG TAB, at $0.44985 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $12.42 for 30 tablets, at an average of $0.41408 per EA in 2024 (2024-01-01 to 2024-12-31) for “Valsartan-Hydrochlorothiazide” and “Valsartan/Hydrochlorothiazide”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 1,711,897 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for VALSARTAN-HYDROCHLOROTHIAZIDE 160-12.5 MG TAB labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Valsartan-Hydrochlorothiazide / Valsartan/Hydrochlorothiazide: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic classes
Related in the same class
- LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB
- OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB
- IRBESARTAN-HYDROCHLOROTHIAZIDE 150-12.5 MG TB
- MICARDIS HCT 40-12.5 MG TABLET
- TRIBENZOR 40-10-25 MG TABLET